P
Partex
First digital pharma platform that is set to be the largest AI-powered Drug Assets Manager
About Partex
Partex.io is at the forefront of transforming the Life Sciences Healthcare sector by leveraging the power of artificial intelligence and blockchain technology. The company focuses on three core areas: Data, AI, and Assets, creating a unique position in the market and aiming to become the Digital Pharma. Partex.io serves clients in the healthcare and life sciences industries, including pharmaceutical companies, research institutions, and healthcare providers. The business model revolves around providing advanced technological solutions that enhance the efficiency and effectiveness of healthcare systems. Partex.io generates revenue through partnerships, licensing its technology, and offering consulting services. The company's holistic approach ensures that it not only competes but also transforms the industry, driving positive societal impact by increasing health, longevity, and equitability.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- Eschborn, Germany
- Employees
- 186
- Open positions
- None listed
- Dealroom signal
- 92.2/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Drug Development, Core AI
- Technology
- Blockchain, Artificial Intelligence, Big Data, Deep Tech, Machine Learning, Deep Learning
- Business model
- SaaS
- Client focus
- b2b
- Investment activity
- 5 companies, latest Jan 2021
- Capital deployed
- $0
- Preferred round
- CORPORATE SPINOUT
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEEDEquity / VC | May 2023 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Partex is 7.2K monthly website visits, up 89.5% over the last three months. Partex's team grew 89.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
CureteqZug, SwitzerlandCureteq is an asset management and drug development company enabled by artificial intelligence (AI)
→
PerpetualblockPune, IndiaMaking assets bankable through tokenisation and support innovation and efficiency with scalable data analytics and ML
→
AmritEschborn, GermanyA global data exchange marketplace-licensing consented data for drug discovery programs, patients get incentivized
→
Assay.WorksRegensburg, GermanyAssay.Works is a contract research organization (CRO) providing research services to pharmaceutical/biotech companies and academic organizations in form of fee-for-service work
→
InnoplexusEschborn, GermanyAI and Blockchain powered data analytics solutions help the life science industry gain real-time access to relevant insights
→
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors2 additional known investors
C3 Venture Capital
Eragon Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Partex on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Partex’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.